Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Drug Safety|August 1, 1996
Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')U D McCann, S O Slate, G A RicaurteBrain Research|April 5, 1991
Major metabolites of (+/-)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neuronsU D McCann, G A RicaurteJournal of Clinical Psychopharmacology|October 1, 1991
Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational usersU D McCann, G A RicaurteNIDA Research Monograph|January 1, 1993
Strategies for detecting subclinical monoamine depletions in humansU D McCann, G A RicaurteAnnals of the New York Academy of Sciences|May 11, 1992
Neurotoxic amphetamine analogues: effects in monkeys and implications for humansG A Ricaurte, U D McCannNeurotoxicity Research|April 28, 2004
Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neuronsG A Ricaurte, U D McCannJournal of Clinical Psychopharmacology|June 1, 1993
Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidenceU D McCann, G A RicaurteThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 15, 1999
Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recoveryG Hatzidimitriou, U D McCann, G A RicaurteEuropean Journal of Pharmacology|September 5, 1995
Fenfluramine's appetite suppression and serotonin neurotoxicity are separableU D McCann, J Yuan, G A RicaurteEuropean Journal of Pharmacology|September 26, 1996
Prolactin response to fenfluramine is independent of serotonin releaseU D McCann, G Hatzidimitriou, G A RicaurtePageof 11